Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients

References

• Durcan L, O'Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332–2343.
   PubMed Web of Science ®Google Scholar
• Jakes RW, Bae SC, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64(2):159–168.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):Itc81–itc96.
   PubMed Web of Science ®Google Scholar
• Idborg H, Eketjäll S, Pettersson S, et al. TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus. Lupus Sci Med. 2018;5(1):e000260.
   PubMed Web of Science ®Google Scholar
• Gane JM, Stockley RA, Sapey E. TNF-α autocrine feedback loops in human monocytes: the pro- and anti-Inflammatory roles of the TNF-α receptors support the concept of selective TNFR1 blockade in vivo. J Immunol Res. 2016;2016:1079851.
   PubMed Web of Science ®Google Scholar
• Borghi A, Verstrepen L, Beyaert R. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. Biochem Pharmacol. 2016;116:1–10.
   PubMed Web of Science ®Google Scholar
• Sharapova TN, Romanova EA, Soshnikova NV, et al. Autoantibodies from SLE patients induce programmed cell death in murine fibroblast cells through interaction with TNFR1 receptor. Sci Rep. 2020;10(1):11144.
   PubMed Web of Science ®Google Scholar
• Adhya Z, El Anbari M, Anwar S, et al. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Lupus. 2019;28(6):713–721.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–1277.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–530.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–470.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Schrauben SJ, Shou H, Zhang X, et al. Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol. 2021;32(1):115–126.
   PubMed Web of Science ®Google Scholar
• Nowak N, Skupien J, Smiles AM, et al. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int. 2018;93(5):1198–1206.
   PubMed Web of Science ®Google Scholar
• Froon AH, Bemelmans MH, Greve JW, et al. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit Care Med. 1994;22(5):803–809.
   PubMed Web of Science ®Google Scholar
• Bergquist M, Samuelsson L, Larsson A, et al. TNFR1, TNFR2, neutrophil gelatinase-associated lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort. Sci Rep. 2020;10(1):15350.
   PubMed Web of Science ®Google Scholar
• Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296(5573):1634–1635.
   PubMed Web of Science ®Google Scholar
• Al-Lamki RS, Wang J, Vandenabeele P, et al. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J. 2005;19(12):1637–1645.
   PubMed Web of Science ®Google Scholar
• Feng YM, Thijs L, Zhang ZY, et al. Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population. Nephrol Dial Transplant. 2018;33(3):426–435.
   PubMed Web of Science ®Google Scholar
• Niewczas MA, Pavkov ME, Skupien J, et al. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med. 2019;25(5):805–813.
   PubMed Web of Science ®Google Scholar
• Lee SM, Yang S, Cha RH, et al. Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy. PLoS One. 2014;9(8):e104354.
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Zelnick LR, Shlipak M, et al. Association of soluble TNFR-1 concentrations with long-term decline in kidney function: the multi-ethnic study of atherosclerosis. J Am Soc Nephrol. 2018;29(11):2713–2721.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Schmidt IM, Palsson R, et al. The associations of plasma biomarkers of inflammation with histopathologic lesions, kidney disease progression, and mortality-the Boston kidney biopsy cohort study. Kidney Int Rep. 2021;6(3):685–694.
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Gohda T, Suzuki Y, et al. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS One. 2015;10(4):e0122212.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Mora-Fernández C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev. 2006;17(6):441–450.
   PubMed Web of Science ®Google Scholar
• Zheng CZ, Yan WW, Luo YL, et al. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis. Eur Rev Med Pharmacol Sci. 2020;24(10):5582–5591.
   PubMed Web of Science ®Google Scholar
• Aten J, Roos A, Claessen N, et al. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol. 2000;11(8):1426–1438.
   PubMed Web of Science ®Google Scholar
• Hill GS, Delahousse M, Nochy D, et al. Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int. 2001;60(5):1893–1903.
   PubMed Web of Science ®Google Scholar